跳至主要内容
临床试验/NCT00542139
NCT00542139已完成4 期

Evaluation of the Efficacy of Diprospan Injection to the Knee on Rehabilitation of Patients With Bilateral Knee Osteoarthritis After TKR of the Contralateral Knee.

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Visual analogue pain score

研究概览

简要总结

This study is performed to assess the influence of intraarticular injection of 2ml Diprospan (wich contains 4mg Betamethasone sodium phosphate and 10mg Betamethasone dipropionate) into osteoarthritic knee in patients who undergo a total knee replacement of their contralateral knee.

The study population will include 50 patients with bilateral knee osteoarthritis, admitted for their first knee replacement surgery. Only patients with older than 50 years with primary osteoarthritis will be included. The patients will be randomized into 2 groups. Intervention group will receive an injection of 2ml Diprospan diluted in 10 ml Bupivocaine. The control group will receive an injection of 10ml of Bupivocaine. All patients will be followed after 6 weeks and three functional rehabilitation and pain scores will be assessed (VAS pain score, Timed Up and Go Score and Functional Ambulatory Category Scale).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age older than 50
  • Bilateral primary knee osteoarthritis
  • Undergoing knee arthroplasty

排除标准

  • Active infection
  • Allergy to medication compounds
  • Pregnancy

研究组 & 干预措施

1

Experimental

干预措施: Betamethasone (Drug)

2

Active Comparator

干预措施: Bupivocaine (Drug)

结局指标

主要结局

Visual analogue pain score

时间窗: 6 weeks

次要结局

  • Timed Up and Go Score(6 weeks)
  • Functional Ambulatory Category Scale(6 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验